{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:15:58Z","timestamp":1768641358230,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1006\/cyto.1999.0645","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:48Z","timestamp":1032191148000},"page":"1084-1091","source":"Crossref","is-referenced-by-count":19,"title":["ELEVATED PLASMA TGF-\u03b21 IN RENAL DISEASES: CAUSE OR CONSEQUENCE?"],"prefix":"10.1006","volume":"12","author":[{"given":"U","family":"Junker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C","family":"Haufe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nuske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Rebstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/cyto.1999.0645_RF1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/1043-4666(94)90062-0","article-title":"Transforming growth factor-\u03b21 (TGF-\u03b21) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production","volume":"6","author":"Reinhold","year":"1994","journal-title":"Cytokine"},{"key":"10.1006\/cyto.1999.0645_RF2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/jir.1995.15.685","article-title":"Transforming growth factor \u03b21 inhibits Interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells","volume":"15","author":"Reinhold","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1006\/cyto.1999.0645_RF3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/jir.1997.17.95","article-title":"Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta-a in primary cultures and modulate lymphocyte blast transformation","volume":"17","author":"Knoefel","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"10.1006\/cyto.1999.0645_RF4","first-page":"434","article-title":"The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors","volume":"133","author":"Bergh","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1006\/cyto.1999.0645_RF5","first-page":"1115","article-title":"Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues","volume":"10","author":"Mizukami","year":"1990","journal-title":"Anticancer Res"},{"key":"10.1006\/cyto.1999.0645_RF6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1996.0105","article-title":"Transforming growth factor \u03b21 is significantly elevated in plasma of patients suffering from renal cell carcinoma","volume":"8","author":"Junker","year":"1996","journal-title":"Cytokine"},{"key":"10.1006\/cyto.1999.0645_RF7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0022-5347(01)64805-5","article-title":"Serum transforming growth factor-beta-1 in patients with renal cell carcinoma","volume":"157","author":"Wunderlich","year":"1997","journal-title":"J Urol"},{"key":"10.1006\/cyto.1999.0645_RF8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X","article-title":"Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and ist significant decrease after curative surgical resection","volume":"85","author":"Shim","year":"1999","journal-title":"Cancer"},{"key":"10.1006\/cyto.1999.0645_RF9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.1999.17.2.607","article-title":"Role of transforming growth factor-\u03b21 in invasion and metastasis in gastric carcinoma","volume":"17","author":"Maehara","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1006\/cyto.1999.0645_RF10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jso.2930550307","article-title":"Selective depression of T-lymphocyte subsets in gastric cancer patients: an implication of immunotherapy","volume":"55","author":"Lee","year":"1994","journal-title":"J Surg Oncol"},{"key":"10.1006\/cyto.1999.0645_RF11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3468(99)90358-5","article-title":"TGF-beta1 alters the healing of cutaneous fetal excisional wounds","volume":"34","author":"Lanning","year":"1999","journal-title":"J Pediatr Surg"},{"key":"10.1006\/cyto.1999.0645_RF12","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1161\/01.CIR.96.11.3888","article-title":"Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factor AB","volume":"96","author":"Schini-Kerth","year":"1997","journal-title":"Circulation"},{"key":"10.1006\/cyto.1999.0645_RF13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2249.1994.tb06086.x","article-title":"Intraglomerular expression of transforming growth factor-\u03b21 (TGF-\u03b21) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction","volume":"97","author":"Iwano","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/cyto.1999.0645_RF14","first-page":"1061","article-title":"Transforming growth factor \u03b2 (TGF beta) activity in urine of patients with glomerulonephritis","volume":"1995","author":"Dominguez","year":"1995","journal-title":"Braz J Med Biol Res"},{"key":"10.1006\/cyto.1999.0645_RF15","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1073\/pnas.92.7.2572","article-title":"Hepatic expression of mature transforming growth factor \u03b21 in transgenic mice results in multiple tissue lesions","volume":"92","author":"Sanderson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/cyto.1999.0645_RF16","first-page":"362","article-title":"Elevated D-glucose concentrations modulate TGF-\u03b21 synthesis by human cultured renal proximal tubular cells: the permissive role of platelet-derived growth factor","volume":"147","author":"Phillips","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1006\/cyto.1999.0645_RF17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000057369","article-title":"Potential role of TGF-\u03b2 in diabetic nephropathy","volume":"24","author":"Hoffman","year":"1998","journal-title":"Miner Electrolyte Metab"},{"key":"10.1006\/cyto.1999.0645_RF18","first-page":"991","article-title":"Transgenic mice with increased plasma levels of TGF-\u03b21 develop progressive renal disease","volume":"74","author":"Kopp","year":"1996","journal-title":"Lab Invest"},{"key":"10.1006\/cyto.1999.0645_RF19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-1759(93)90254-5","article-title":"Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta-1","volume":"158","author":"Danielpour","year":"1993","journal-title":"J Immunol Meth"},{"key":"10.1006\/cyto.1999.0645_RF20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-1759(97)00160-9","article-title":"Letter to the editors: a detailed protocol for the measurement of TGF-beta-1 in human blood samples","volume":"209","author":"Reinhold","year":"1997","journal-title":"J Immunol Meth"},{"key":"10.1006\/cyto.1999.0645_RF21","first-page":"129","article-title":"Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer","volume":"1","author":"Wakefield","year":"1995","journal-title":"Clin Cancer Res"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466699906452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466699906452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T16:28:40Z","timestamp":1557332920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466699906452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S1043466699906452"],"URL":"https:\/\/doi.org\/10.1006\/cyto.1999.0645","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}